MMP9 and nasopharyngeal carcinoma: Liu and colleagues [85] synthetized a copolymer with β-cyclodextrin (CD) core and poly(l-lysine) dendron (PLLD) to co-deliver docetaxel antitumor drug and MMP-9 siRNA plasmid for nasopharyngeal carcinoma therapy.